APOTHEEK ANDRÉ DUMONT financials
A multi-period view of the public annual-account figures reported for APOTHEEK ANDRÉ DUMONT, with comparable measures and links to available source documents.
Company overviewRegistry number
0418632501
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 29, 2026
Financial evidence
Latest movements for APOTHEEK ANDRÉ DUMONT
2025 versus 2024
- Operating line
- €544,713
- EBITDA
- €230,440
- Total assets
- €1,695,053
- Equity
- €415,644
+4.7%
+41%
+0.1%
+1.8%
EBITDA margin +42.3% · Equity ratio +24.5%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €544,713 | €230,440 | €1,695,053 | €415,644 | - |
| 202431 Dec 2024 | €520,019 | €163,486 | €1,693,363 | €408,221 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.